What predicts survival in glioblastoma? A population-based study of changes in clinical management and outcome.

Fekete, B; Werlenius, K; Tisell, M; Pivodic, A; Smits, A; Jakola, A S; Rydenhag, B

Fekete, B; Werlenius, K; Tisell, M; Pivodic, A; Smits, A; Jakola, A S; Rydenhag, B.

Afiliação

Fekete B; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Werlenius K; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Tisell M; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pivodic A; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Smits A; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jakola AS; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Rydenhag B; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Front Surg ; 10: 1249366, 2023.

Article em En | MEDLINE | ID: mdl-37711136

Palavras-chave

glioblastoma; population-based; prognostic factors; survival; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Surg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google